New biomarkers could unlock faster diagnosis for rare blood disorder
NCT ID NCT01713504
First seen Jan 09, 2026 · Last updated May 16, 2026 · Updated 19 times
Summary
This study looked for new markers in the blood that could help doctors diagnose hypereosinophilic syndrome more easily and accurately. Researchers used a protein analysis method to compare samples from 41 participants. The goal is to make diagnosis simpler and more reliable than current methods.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPEREOSINOPHILIC SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHRU, Hôpital Claude Huriez
Lille, Nord, 59037, France
Conditions
Explore the condition pages connected to this study.